{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:40:03Z","timestamp":1777855203703,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["- IG 2019"],"award-info":[{"award-number":["- IG 2019"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23015"],"award-info":[{"award-number":["23015"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.radonc.2024.110160","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T11:41:07Z","timestamp":1708083667000},"page":"110160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial"],"prefix":"10.1016","volume":"194","author":[{"given":"C.","family":"Fiorino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Albarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Damascelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pavarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Passoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Slim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Steidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.G.","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110160_b0005","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.radonc.2024.110160_b0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0015","doi-asserted-by":"crossref","unstructured":"D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS et al. International Esodata Study Group. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001\/jamasurg.2021.2376. Erratum in: JAMA Surg. 2021;156(9):894.","DOI":"10.1001\/jamasurg.2021.2377"},{"key":"10.1016\/j.radonc.2024.110160_b0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13014-021-01947-7","article-title":"Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis","volume":"16","author":"Park","year":"2021","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/SLA.0000000000003636","article-title":"Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study","volume":"274","author":"van der Wilk","year":"2021","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12029-016-9870-0","article-title":"Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus","volume":"48","author":"Dewan","year":"2017","journal-title":"Journal of Gastrointestinal Cancer"},{"key":"10.1016\/j.radonc.2024.110160_b0035","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/PAS.0000000000000420","article-title":"Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy","volume":"39","author":"Agoston","year":"2015","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1016\/j.radonc.2024.110160_b0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s11605-016-3177-0","article-title":"Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma","volume":"20","author":"Alnaji","year":"2016","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s11605-013-2269-3","article-title":"Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?","volume":"17","author":"Castoro","year":"2013","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","article-title":"Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study","volume":"19","author":"Noordman","year":"2018","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/bjs.11094","article-title":"Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer","volume":"106","author":"Vollenbrock","year":"2019","journal-title":"The British Journal of Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/SLA.0000000000003397","article-title":"Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis","volume":"271","author":"Eyck","year":"2020","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13304-022-01377-4","article-title":"Does radiomics play a role in the diagnosis, staging and re-staging of gastroesophageal junction adenocarcinoma?","volume":"75","author":"Mori","year":"2023","journal-title":"Updates in Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s11605-023-05611-1","article-title":"Sarcopenia and Patient's Body Composition: New Morphometric Tools to Predict Clinical Outcome After Ivor Lewis Esophagectomy: a Multicenter Study","volume":"27","author":"Cossu","year":"2023","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.radonc.2024.110160_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2015.04.027","article-title":"Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer","volume":"115","author":"van Rossum","year":"2015","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0080","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/0284186X.2018.1473637","article-title":"DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer","volume":"57","author":"Heethuis","year":"2018","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.radonc.2024.110160_b0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2016.10.021","article-title":"The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy","volume":"121","author":"Wang","year":"2016","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0090","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00330-013-2807-0","article-title":"Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology","volume":"23","author":"De Cobelli","year":"2013","journal-title":"European Radiology"},{"key":"10.1016\/j.radonc.2024.110160_b0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ijrobp.2019.12.038","article-title":"Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET\/CT and DW-MRI: A Prospective Multicenter Study","volume":"106","author":"Borggreve","year":"2020","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110160_b0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1148\/radiol.09091324","article-title":"Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review","volume":"254","author":"Kwee","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2024.110160_b0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2967\/jnumed.115.163766","article-title":"The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer","volume":"57","author":"van Rossum","year":"2016","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.radonc.2024.110160_b0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1148\/radiol.2018172229","article-title":"Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer","volume":"287","author":"Beukinga","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2024.110160_b0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2010.12.063","article-title":"Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results","volume":"82","author":"Lambrecht","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110160_b0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13014-021-01852-z","article-title":"Diffusion-weighted MRI and 18F-FDG PET\/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma","volume":"16","author":"Xu","year":"2021","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0125","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2018.02.029","article-title":"Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer","volume":"102","author":"Fang","year":"2018","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110160_b0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/0284186X.2020.1759819","article-title":"Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI","volume":"59","author":"Defize","year":"2020","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.radonc.2024.110160_b0135","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1007\/s00330-022-09111-9","article-title":"Quantitative RECIST derived from multiparametric MRI in evaluating response of esophageal squamous cell carcinoma to neoadjuvant therapy","volume":"32","author":"Qu","year":"2022","journal-title":"European Radiology"},{"key":"10.1016\/j.radonc.2024.110160_b0140","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s00330-019-06513-0","article-title":"Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer","volume":"30","author":"Borggreve","year":"2020","journal-title":"European Radiology"},{"key":"10.1016\/j.radonc.2024.110160_b0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","article-title":"A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer","volume":"128","author":"Fiorino","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0150","first-page":"12","article-title":"Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index","volume":"19","author":"Fiorino","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110160_b0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2020.05.019","article-title":"Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration","volume":"149","author":"Broggi","year":"2020","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0160","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ijrobp.2020.07.2323","article-title":"External validation of an early regression index (ERITCP) as predictor of pathological complete response in rectal cancer using MR-guided Radiotherapy","volume":"185","author":"Cusumano","year":"2020","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110160_b0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2022.07.001","article-title":"Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images","volume":"174","author":"Cusumano","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mric.2019.08.001","article-title":"Esophagus and Stomach: Is There a Role for MR Imaging?","volume":"28","author":"De Cobelli","year":"2020","journal-title":"Magnetic Resonance Imaging Clinics of North America"},{"key":"10.1016\/j.radonc.2024.110160_b0175","first-page":"2680","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Clinicopathologic correlations Cancer"},{"key":"10.1016\/j.radonc.2024.110160_b0180","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ejso.2021.02.001","article-title":"Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer","volume":"47","author":"de Vos-Geelen","year":"2021","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0185","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s00259-022-05677-0","article-title":"68Ga-DOTATOC PET\/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours","volume":"49","author":"Mapelli","year":"2022","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.radonc.2024.110160_b0190","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/RLU.0000000000004064","article-title":"Hybrid PET\/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort","volume":"47","author":"Ironi","year":"2022","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1016\/j.radonc.2024.110160_b0195","unstructured":"Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Palmisano A, Cucchiara V et al. 68Ga-PSMA and 68Ga-DOTA-RM2 PET\/MRI in Recurrent Prostate Cancer."},{"key":"10.1016\/j.radonc.2024.110160_b0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.adro.2019.04.004","article-title":"Gross tumor delineation in esophageal cancer on MRI compared with 18F-FDG-PET\/CT","volume":"4","author":"Vollenbrock","year":"2019","journal-title":"Adv Rad Oncol"},{"key":"10.1016\/j.radonc.2024.110160_b0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2020.11.032","article-title":"Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer","volume":"156","author":"Thomas","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2024.110160_b0215","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:20:44Z","timestamp":1777504844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S0167814024000811"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110160","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110160"}}